Printer Friendly

Importance of SERCA2a on early isolated diastolic dysfunction induced by supravalvular aortic stenosis in rats.


Cardiac remodeling (CR) can be defined as changes in genetic expression, reflected in alterations in molecular, structural and functional characteristics, as a response to specific aggressions, such as ischemia, inflammation, genetic mutations and volumetric or pressure overload (1-3). CR is time-dependent and in the long term it may be a threat, constituting an important risk factor for the development of ventricular dysfunction and heart failure (HF) (4).

Sarcoplasmic reticulum calcium ATPase cardiac isoform 2a (SERCA2a) is among the several factors that control cardiac function (5). The activity of this protein, which works by recapturing calcium into the sarcoplasmic reticulum during diastole, is an important determinant to myocardial performance (6). A wide spectrum of studies in humans relating SERCA2a to systolic HF can be found in the literature, showing a decrease in both its transcription and translation (7-10). The possibility of this protein being connected to HF pathophysiology has inspired experimental studies involving transgenic animals. Louch et al. (11), using a SERCA2a knock-out mice model, reported increased diastolic and systolic dysfunction in these animals. On the other hand, some studies have found that SERCA2a overexpression was followed by an improvement in contractile and relaxation function in failing hearts (12-14). Regarding non-transgenic experimental models for HF, such as spontaneously hypertensive animals and dilated cardiomyopathy, the literature generally seems to agree about the decrease in SERCA2a at systolic dysfunction (15-17). There also seems to be a consensus that SERCA2a levels decrease in myocardial dysfunction with severe heart failure, which are cases with both systolic and diastolic impairment induced by aortic stenosis (AoS) (18). Despite this evidence, there is no available study evaluating the relationship between SERCA2a levels and heart function in hypertrophy models, specifically supravalvular AoS, with isolated diastolic dysfunction at an early stage diagnosed by echocardiogram.

The objective of this research was to evaluate the participation of SERCA2a in premature diastolic impairment, with improved or normal systolic function in hypertrophied hearts induced by supravalvular AoS.

Material and Methods

Animal care

Thirty-day-old male Wistar rats (60-80 g) obtained from the Animal Center of Faculdade de Medicina de Botucatu, UNESP (Botucatu, SP, Brazil) were housed in individual cages. The environment was controlled in terms of light (12-h light/dark cycle starting at 6:00 am) and clean-air room temperature (23[degrees]C). All experiments and procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Research Council (1996) and were approved by the Faculdade de Medicina de Botucatu Ethics Committee (No. FMB-PE-69/2009).

Experimental protocol

Aortic stenosis surgery and experimental groups. The supravalvular AoS model is well established in scientific literature as a left ventricle (LV) hypertrophy promoter (3,4,19-24). It is defined by an initial light overload followed by a slow progression, proportional to the animal's growth.

The rats were submitted to anesthesia with ketamine (50 mg/kg, im). A thoracotomy was performed and a silver band (0.6 mm of internal diameter) placed around the ascending aorta, as previously described (25), constituting the AoS group (n=32). For the control group, rats were submitted to the same surgery but without aortic banding (Sham, n=32). After 6 weeks, all animals were submitted to echocardiogram and subdivided into two different experiments, according to treatment: SERCA2a blockage (Sham, n=15; AoS, n=11) or hypoxia (Sham, n=16; AoS, n=18).

Exclusion criteria for this study were animals showing clinical or laboratory evidence of systolic dysfunction or heart failure.

In vivo functional and structural study. All rats were submitted to echocardiographic evaluation 6 weeks after surgery, since previous studies have shown a diastolic dysfunction and improved systolic function progression from 2 to 6 weeks (3). A commercially available echocardiograph (General Electric Medical Systems, Vivid S6, Israel) equipped with a 5-11.5 MHz multi-frequency probe, was employed as previously described (26-29). Rats were anesthetized by intramuscular injection of a mixture of ketamine (50 mg/kg) and xylazine (0.5 mg/kg). The following structural variables were measured: left atrium diameter (LA), LV diastolic and systolic diameters (LVDD and LVSD, respectively), LV diastolic posterior wall thickness (DPWT), relative wall thickness (RWT) and the aortic diameter (AO). Left ventricular function was assessed by the following parameters: heart rate (HR), midwall fractional shortening (FS), ejection fraction (EF), early and late diastolic mitral inflow velocities (E and A waves) and E/A ratio.

In vitro functional study. According to the protocol currently employed in our laboratory (30,31), under anesthesia and following a thoracotomy the hearts were quickly removed and placed in oxygenated Krebs-Henseleit solution at 28[degrees]C. The papillary muscle was dissected carefully from the left ventricle, clipped at its edges, placed vertically in a chamber containing Krebs-Henseleit solution at 28[degrees]C, oxygenated with a mixture of 0.95 [O.sub.2] and 0.5 C[O.sub.2], pH 7.38, and stimulated with two electrodes inside the solution at a rate of 0.2 Hz. The basal composition of Krebs-Henseleit solution in mM was as follows: 118.5 NaCl, 4.69 KCl, 2.5 Ca[Cl.sub.2], 1.16 MgS[O.sub.4], 5.50 glucose and 25.88 NaHC[O.sub.3]. After a 60-min period, during which preparations were allowed to shorten while carrying light loads, muscles were loaded to contract isometrically and stretched to the apices of their length-tension curves. After a 5-min period, during which preparations performed isotonic contractions, muscles were again placed under isometric conditions and the apex of the length-tension curve ([L.sub.max]) was determined.

The following basal parameters were measured from isometric contraction: peak developed tension (DT,g/[mm.sup.2]), resting tension (RT, g/[mm.sup.2]), time to peak tension (TPT, ms), maximum rate of tension development (+dT/dt, g x[ mm.sup.-2] x [s.sup.-1]) and maximum rate of tension decline (-dT/dt, g x [mm.sup.-2] x [s.sup.-1]). The mechanical behavior of papillary muscle was evaluated in basal condition, after hypoxia and SERCA2a blockage by cyclopiazonic acid (CPA). Since SERCA2a is an ATPase and oxygendependent, we submitted the IPM of both groups to hypoxia, targeting to evaluate whether the group with AoS presented any oxygenation deficits (32), by bubbling the solution through with 0.50 [O.sub.2], 0.45 [N.sub.2] and 0.05 C[O.sub.2]. During reoxygenation, the original 0.95 [O.sub.2] and 0.05 C[O.sub.2] gas mixture was used. The SERCA2a blockage was performed using the highly specific blocker CPA (Penicillium cyclopium, Sigma[R]-Aldrich, USA), 30 mM, in the presence of cumulative calcium concentrations (0.5, 1.5 and 2.5 mM). Sixty minutes after CPA addition to the solution, each concentration of calcium was separately added to the bathing solution, and the papillary muscle response was analyzed 10 min after the addition. DT, RT and -dt/DT are reported as percentage of recovery (%), in relation to each calcium concentration's value before CPA. CPA solution was prepared as described previously by Badaoui et al. (33), by mixing 5 mL of dimethyl sulfoxide (DMSO) to the 10 mg recipient of CPA and then adding 252 [micro]L of such solution to each chamber already filled with 50 [micro]L of Krebs-Henseleit solution.

Papillary muscle cross-sectional area (CSA) was calculated from muscle weight and length by assuming cylindrical uniformity and specific gravity of 1.0. All force data were normalized for muscle CSA. Papillary muscles with CSA > 1.5 [mm.sup.2] were excluded from analysis as they can present central core hypoxia and impaired functional performance.

Postmortem structural study. At the completion of the functional study, the right and left ventricles (including the interventricular septum) were dissected, separated and weighed. Measurements of right and left ventricle and atria weight, normalized by final body weight, were used as hypertrophy indexes. Lungs and liver wet weight/dry weight were employed to determine whether there was an increase in body water.

Molecular study. The myocardial SERCA2a levels in both groups were evaluated by protein expression. As the function of SERCA2a is modulated by its physical interaction with the phosphoprotein phospholamban (PLB), which inhibits SERCA2a activity in its unphosphorylated state, PLB protein expression and the SERCA2a/PLB ratio were also determined. These proteins were assessed by western blot analysis according to the currently accepted procedure.

Histological analysis of total collagen in left ventricle. Samples of the left ventricle were put in a 10% solution of formaldehyde in water over 24 h. Next, the tissue was washed in running water for 24 h and then transferred to an ethanol 70% solution and included in a paraffin block. Five-micrometer histological slices were stained with Picrosirius red. We analyzed 9 Sham and 8 AoS animals, using an average of 30-40 microscopic fields per slide, and the myocardial fibrosis analysis was performed through interstitial collagen quantification. The histological slices were projected in a 40-time increase with a LEICA microscope (Leica Microsystems CMS, Germany), connected with a video camera, which sent the digital images to a computer with an image analysis software (Image Pro-plus, Media Cybernetics, USA). The components of the tissue were identified according to its color: red meaning collagen fibers; yellow, myocytes and white, interstitial space.

Statistical analysis

Data from general characteristics, cardiac function and molecular analysis are reported as means [+ or -] SD. Comparisons between groups were performed using Student's t-test for independent samples. Data from the hypoxia experiment are reported as means [+ or -] SD and submitted to the multivariate analysis for repeated measures model in independent groups, complemented with the Bonferroni's multiple comparison test. Collagen data were analyzed using Mann-Whitney test for non-parametric measures. SERCA2a blockage maneuver is reported as median, maximum (max) and minimum (min) value, and studied using analysis of variance for repeated measures, complemented with the multiple comparison test of Student-Newman-Keuls, with a level of significance of 0.05.


Postmortem morphological study

Table 1 shows the morphological analysis performed after euthanasia of both groups. AoS promoted a greater LV, right ventricle (RV) and atria (AT) weight, while it preserved final body weight. Moreover, there was no statistically significant difference between groups as to wet and dry weight of lungs and liver, which proves that those animals did not have heart failure, one of the exclusion criteria for this study.

In vivo functional and structural study

Table 2 summarizes the echocardiographic evaluation of both groups. There was statistical difference in structural data: LV relative wall thickness and LA/AO were significantly greater in the AoS group. There was no change in either EF or midwall FS (%), showing preserved systolic function. However, there was a difference in E wave and E/A, which were greater in AoS.

In vitro functional study

The evaluation of in vitro myocardial function using isolated papillary muscle in basal condition is represented in Table 3. The 6-week exposure to supravalvular AoS provoked a significant increase in RT and TPT, when compared to control group, while + dT/dt was decreased in the AoS group.

The influence of muscular length variation over RT is reported in Figure 1. There was a significant increase in RT in AoS compared to Sham rats.

The effects of hypoxia over papillary muscle, in relative values (%), regarding basal condition, are reported in Figure 2A and B. Sham and AoS groups achieved

75.3 [+ or -] 5.4 and 73.7 [+ or -] 6.6% of their respective basal condition DT, P>0.05. RT was increased to 137 [+ or -]29 and 131 [+ or -] 21% of Sham and AoS basal condition, respectively, P>0.05. There was also no difference between groups after reoxygenation, for both DT (Sham: 89.2 [+ or -] 4.6%; AoS: 90.4 [+ or -] 4.2%, P>0.05) and RT (Sham: 91.7 [+ or -] 16.1; AoS: 97.0 [+ or -] 11.0%, P>0.05). However, there was a significant difference in both parameters at reoxygenation with respect to hypoxia within each group (P< 0.001).

The effects of the SERCA2a blockage with CPA over DT, RTand -dT/dt are reported in Table 4, in percentage of basal conditions in each calcium concentration, in median, min and max. Both groups suffered a significant decrease on DT after adding CPA, reaching a maximum of 83% of basal condition DT (AoS, 2.5 mM Ca), thus demonstrating the efficacy of CPA blockage, which naturally will diminish contractile function due to its SERCA2a blockage mechanism. DT was different between groups AoS and Sham in all moments analyzed, maintaining the difference found in basal conditions, where AoS had greater systolic function, and also within groups between 2.5 and 0.5 mM of calcium, showing the importance of calcium concentration in contraction. As to RT, there was no difference between groups AoS and Sham in any moment analyzed. However, RT was greater within the AoS group at 1.5 and 2.5 compared to 0.5 mM of calcium, P<0.05. Also, at 2.5 mM calcium concentration, the AoS group presented a lower relaxation speed, described as -dT/dt compared to Sham, another indicator of diastolic dysfunction.

Molecular study

Data regarding western blot results are shown in Figure 3A-C. Quantified SERCA2a was similar between groups (Sham=1.00 [+ or -] 0.18; AoS=1.10 [+ or -] 0.19; P=0.32), as well as PLB (Sham=1.00 [+ or -] 0.23; AoS=1.30 [+ or -] 0.37; P=0.12) and SERCA2a/PLB ratio (Sham=1.03 [+ or -] 0.20; AoS=0.87 [+ or -] 0.17; P=0.16).

Histological analysis of total collagen in left ventricle

Data concerning Picrosirius red staining are shown in Figure 4C. Analysis showed a difference between groups (P=0.001), based on the percentage of total collagen. Figure 4A and B illustrates the procedure and shows the difference found: myocytes were increased in size, showing the hypertrophy described previously, and the red color was much stronger in the AoS group.


The main goal of this study was to determine whether SERCA2a played a role in early isolated diastolic dysfunction assessed by echocardiogram in left ventricular hypertrophy caused by supravalvular AoS, by employing protein blocking during the isolated papillary study complemented by a molecular analysis. The results showed that such model was adequate for its purposes as it led, after 6 weeks, to an increase in the left atrium, E/A relation and preservation of ejection fraction. The diastolic dysfunction was then successfully reproduced in isolated papillary muscle, where there was an increased RT in basal conditions, as well as during muscle stretching, which is basically what was expected, since RT is the in vitro equivalent of diastolic function. Our functional studies showed that SERCA2a does participate in the diastolic dysfunction provoked by AoS.

The echocardiogram showed that the AoS group had wider left atrium, thicker muscle wall and greater relative wall thickness in the left ventricle - compatible with concentric hypertrophy -, preserved ejection and midwall fraction shortening and a higher E/A relation, consistent with isolated diastolic dysfunction. As A wave was similar between groups, such difference was due to E wave, which was increased in AoS. These data lead us to classify these hearts in early diastolic dysfunction, because the A wave had not yet fallen. The majority of previous studies in our laboratory had not found such an increase in E/A relation (20,24,25).

Post-mortem analysis confirmed the morphologic echocardiogram data, as it showed heavier left ventricle, atria and right ventricle in the AoS group, consistent with previous studies (19). This information confirms cardiac hypertrophy, but puts in question whether there was also a right-side insufficiency. The similarity in lung and liver wet weight over dry weight between groups clarified that question and corroborated the isolated left diastolic dysfunction without heart failure.

When transporting the functional study to an in vitro environment, with isolated papillary muscle, basal condition showed preserved DT, diminished + dT/dt and increased TPT. What can be stated from that is that the AoS muscle had, as previously seen in echocardiogram, preserved systolic function. However, despite similar DT between groups, the alterations in both TPT and + dT/dt may show a decreased quality of contraction, even with an acceptable end result, which may indicate a change in myosin pattern with increased expression of its heavy chain slow isoform (34). As to RT, it was increased in the AoS group in basal conditions and during muscle stretching, where there was an important difference in the AoS group behavior, showing greater myocardial rigidity in comparison with the control group. These findings could be related to remaining calcium bound to C troponin secondary to an increase in end-diastole cytosolic calcium, along with excess of other proteins, such as titin, the components of extracellular matrix, cytoskeleton and structural alterations, due to the addition of sarcomeres in parallel that may also diminish ventricular compliance in AoS (35).

Therefore, we performed an analysis of the collagen to see whether it might be a component of the inherent increased RT found in AoS, although it would not explain the positive effects of CPA blockage found in that group. Using the Picrosirius red technique, the AoS group was found to have a much larger ratio of collagen/total area.

According to the objective of this study, we intended to analyze the participation of SERCA2a in the early isolated diastolic dysfunction found, through specific blockage of this protein in isolated papillary muscle. However, as SERCA2a is an ATPase, we first had to exclude the possibility of hypoxia interference in the maneuver. Thus, we submitted both groups to a relative hypoxia and analyzed their behavior. Both groups equally improved RT after reoxygenation, and there were no differences between groups regarding this variable during hypoxia. These data show that both groups suffered equally from hypoxia during the experiment, allowing to conclude that the results from SERCA2a blockage would be only due to its activity/number and not to oxygen supply.

The specific SERCA2a blockage with cyclopiazonic acid proved itself effective since it provoked a decrease in systolic function - here represented by DT - in both groups, although with a smaller decrease in the AoS group, probably due to a greater amount of myofilaments available in that group. Such decrease in DT is expected due to the SERCA2a blockage mechanism of CPA, which will impair the calcium transients. The fact the there was no difference between groups as to that variable just reinforces the distinct contractile function found on basal condition. The percentage of recovered RT in relation to each group's basal values was equal between the groups Sham and AoS, at all calcium concentrations. Such finding would at first lead us to believe that the CPA experiment did not have an effect over diastolic function, as SERCA2a blockage would mainly interfere with calcium recapture, thus causing a disruption in myosin-actin detachment. However, the AoS group presented a significant increase in recovered RT at 1.5 and 2.5 mM regarding 0.5 mM calcium concentration, which did not happen in the control group. Also, the speed of relaxation after blockage given by -dT/dt was slower in the AoS animals at 2.5 mM of calcium concentration, which indicates a deficient calcium transient. Although there was no difference between groups for RT, which may have occurred due to the great variability found among Sham animals, the fact that the AoS group presented a distinct behavior from control, with greater RT as calcium concentration increased associated with the slower relaxation found in that group allowed us to infer that the AoS group presented some sort of calcium recapture dysfunction related to SERCA2a. To conclude this protein's analysis, a molecular study was performed, through measuring SERCA2a and its regulator, PLB. Neither of them were increased or decreased in the AoS group, despite evidence of the contrary in the literature, which has found a decrease in both SERCA2a and PLB, not specifying the ratio findings in severe heart dysfunction (4,36,37).

The molecular findings go against the functional study with SERCA2a blockage. Although the present study did not show such decrease in SERCA2a, it is likely that our findings are related to a decreased activity causing recapture speed deficit, as well as to a mismatching relation between this protein and myofibrils content--which are increased in the hypertrophied muscle, only revealed after SERCA2a specific blockage. Summarizing, the results show that the hypertrophied muscle found in the early stage of AoS apparently presented inappropriate SERCA2a activity, which began to jeopardize the relaxation phase of the muscle.

In conclusion, the hypothesis of this study was confirmed, since functional parameters considering the in vitro environment regarding SERCA2a protein were altered in the AoS group, leading us to deduce that this protein must participate in early isolated diastolic dysfunction caused by supravalvular AoS. By being reproducible in in vivo hearts, this finding opens doors to the next step in isolated diastolic dysfunction research: defining targets on which drugs might act in order to stop or prevent the natural evolution of the disease. However, other contributing factors to this condition cannot be excluded for now and should be studied further.


We acknowledge Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, process No. 2009/53208-2) for the financial support of this research.


(1.) Cohn JN, Ferrarri R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 2000; 35: 562-582, doi: 10.1016/S0735-1097(99)00630-0.

(2.) Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000; 102: 470-479, doi: 10.1161/01.CIR.102.4.470.

(3.) Mendes OC, Campos DHS, Damatto RL, Sugizaki MM, Padovani CR, Okoshi K, et al. Remodelamento cardiaco: analise seriada e indices de deteccao precoce de disfuncao ventricular. Arq Bras Cardiol 2010; 94: 62-70, doi: 10.1590/ S0066-782X2010000100011.

(4.) Boluyt MO, Robinson KG, Meredith AL, Sen S, Lakatta EG, Crow MT, et al. Heart failure after long-term supravalvular aortic constriction in rats. Am J Hypertens 2005; 18: 202-212, doi: 10.1016/j.amjhyper.2004.08.034.

(5.) Bers DM. Cardiac excitation-contraction coupling. Nature 2002; 415: 198-205, doi: 10.1038/415198a.

(6.) Periasamy M, Huke S. SERCA pump level is a critical determinant of Ca(2 +)homeostasis and cardiac contractility. J Mol Cell Cardiol 2001; 33:1053-1063, doi: 10.1006/ jmcc.2001.1366.

(7.) Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. CircRes 1993; 72:463-469, doi: 10.1161/01.RES.72.2.463.

(8.) Hasenfuss G. Calcium pump overexpression and myocardial function. Implications for gene therapy of myocardial failure. Circ Res 1998; 83: 966-968, doi: 10.1161/01. RES.83.9.966.

(9.) Lehnart SE, Schillinger W, Pieske B, Prestle J, Just H, Hasenfuss G. Sarcoplasmic reticulum proteins in heart failure. Ann N Y Acad Sci 1998; 853: 220-230, doi: 10.1111/j.17496632.1998.tb08270.x.

(10.) Prestle J, Dieterich S, Preuss M, Bieligk U, Hasenfuss G. Heterogeneous trnasmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc Res 1999; 43: 323-331, doi: 10.1016/ S0008-6363(99)00119-4.

(11.) Louch WE, Hougen K, Mork HK, Swift F, Aronsen JM, Sjaastad I, et al. Sodium accumulation promotes diastolic dysfunction in end-stage heart failure following Serca2 knockout. J Physiol 2010; 588: 465-478, doi: 10.1113/jphysiol. 2009.183517.

(12.) Baker DL, Hashimoto K, Grupp IL, Ji Y, Reed T, Loukianov E, et al. Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts. Circ Res 1998; 83: 1205-1214, doi: 10.1161/01.RES.83.12.1205.

(13.) Miyamoto MI, del Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T, et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A 200014.

(14.) Sakata S, Lebeche D, Sakata N, Sakata Y, Chemaly ER, Liang LF, et al. Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J Mol Cell Cardiol 2007; 42: 852-861, doi: 10.1016/j.yjmcc.2007.01.003.

(15.) Takewa Y, Chemaly ER, Takaki M, Liang LF, Jin H, Karakikes I, et al. Mechanical work and energetic analysis of eccentric cardiac remodeling in a volume overload heart failure in rats. Am J Physiol Heart Circ Physiol 2009; 296: H1117-H1124, doi: 10.1152/ajpheart.01120.2008.

(16.) Ward ML, Crossman DJ, Cannell MB. Mechanisms of reduced contractility in an animal model of hypertensive heart failure. Clin Exp Pharmacol Physiol 2011; 38: 711-716, doi: 10.1111/j.1440-1681.2011.05563.x.

(17.) Ward ML, Crossman DJ, Loiselle DS, Cannell MB. Nonsteady-state calcium handling in failing hearts from the spontaneously hypertensive rat. Pflugers Arch 2010; 460: 991-1001, doi: 10.1007/s00424-010-0876-3.

(18.) Szymanska G, Stromer H, Mim DH, Lorell BH, Morgan JP. Dynamic changes in sarcoplasmic reticulum function in cardiac hypertrophy and failure. Pflugers Arch 2000; 439: 339-348, doi: 10.1007/s004249900097.

(19.) Bregagnollo EA, Mestrinel MA, Okoshi K, Carvalho FC, Bregagnollo IF, Padovani CR, et al. Papel relativo da remodelacao geometrica do ventriculo esquerdo, morfologica e funcional do miocardio na transicao da hipertrofia compensada para a falencia cardiaca em ratos com estenose aortica supravalvar. Arq Bras Cardiol 2007; 88: 225-233, doi: 10.1590/S0066-782X2007000200015.

(20.) Bregagnollo EA, Okoshi K, Bregagnollo IF, Okoshi MP, Padovani CR, Cicogna AC. Effects of the prolonged inhibition of the angiotensin-converting enzyme on the morphological and functional characteristics of left ventricular hypertrophy in rats with persistent pressure overload. Arq Bras Cardiol 2005; 84: 225-232, doi: 10.1590/S0066782X2005000300006.

(21.) Bregagnollo EA, Zornoff LA, Okoshi K, Sugizaki M, Mestrinel MA, Padovani CR, et al. Myocardial contractile dysfunction contributes to the development of heart failure in rats with aortic stenosis. Int J Cardiol 2007; 117: 109-114, doi: 10.1016/j.ijcard.2006.06.006.

(22.) Bruckschlegel G, HolmerSR, Jandeleit K, Grimm D, Muders F, Kromer EP, et al. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 1995; 25: 250-259, doi: 10.1161/01.HYP. 25.2.250.

(23.) Litwin SE, Katz SE, Weinberg EO, Lorell HB, Aurigemma GP, Douglas PS. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 1995; 91: 2642-2654, doi: 10.1161/ 01.CIR.91.10.2642.

(24.) Ribeiro HB, Okoshi K, Cicogna AC, Bregagnollo EA, Rodrigues MAM, Padovani CR, et al. Estudo evolutivo da morfologia e funcao cardiaca em ratos submetidos a estenose aortica supravalvar. Arq Bras Cardiol 2003; 81: 562-568, doi: 10.1590/S0066-782X2003001400003.

(25.) Mendes OC, Sugizaki MM, Campos DS, Damatto RL, Leopoldo AS, Lima-Leopoldo AP, et al. Exercise tolerance in rats with aortic stenosis and ventricular diastolic and/or systolic dysfunction. Arq Bras Cardiol 2013; 100: 44-51, doi: 10.1590/S0066-782X2012005000112.

(26.) Damatto RL, Martinez PF, Lima AR, Cezar MD, Campos DH, Oliveira Junior SA, et al. Heart failure-induced skeletal myopathy in spontaneously hypertensive rats. Int J Cardiol 2013 167: 698-703, doi: 10.1016/j.ijcard.2012.03.063.

(27.) Martinez PF, Okoshi K, Zornoff LA, Oliveira SA Jr, Campos DH, Lima AR, et al. Echocardiographic detection of congestive heart failure in postinfarction rats. J Appl Physiol 2011; 111: 543-551, doi: 10.1152/japplphysiol.01154.2010.

(28.) Minicucci MF, Azevedo PS, Martinez PF, Lima AR, Bonomo C, Guizoni DM, et al. Critical infarct size to induce ventricular remodeling, cardiac dysfunction and heart failure in rats. Int J Cardiol 2011; 151: 242-243, doi: 10.1016/j.ijcard. 2011.06.068.

(29.) Sugizaki MM, Carvalho RF, Aragon FF, Padovani CR, Okoshi K, Okoshi MP, etal. Myocardial dysfunction induced by food restriction is related to morphological damage in normotensive middle-aged rats. J Biomed Sci 2005; 12: 641-649, doi: 10.1007/s11373-005-7652-y.

(30.) Pinotti MF, Leopoldo AS, Silva MD, Sugizaki MM, do Nascimento AF, Lima-Leopoldo AP, et al. A comparative study of myocardial function and morphology during fasting/ refeeding and food restriction in rats. Cardiovasc Pathol 2010; 19: 175-182, doi: 10.1016/j.carpath.2009.08.001.

(31.) Pinotti MF, Silva MD, Sugizaki MM, Diniz YS, Sant'Ana LS, Aragon FF, et al. Effect of unsaturated fatty acids on myocardial performance, metabolism and morphology. Braz J Med Biol Res 2006; 39: 305-312, doi: 10.1590/S0100879X2006000200019.

(32.) Lecarpentier Y, Waldenstrom A, Clergue M, Chemla D, Oliviero P, Martin JL, et al. Major alterations in relaxation during cardiac hypertrophy induced by aortic stenosis in guinea pig. Circ Res 1987; 61: 107-116, doi: 10.1161/01. RES.61.1.107.

(33.) Badaoui A, Huchet-Cadiou C, Leoty C. Effects of cyclopiazonic acid on membrane currents, contraction and intracellular calcium transients in frog heart. J Mol Cell Cardiol 1995; 27: 2495-2505, doi: 10.1006/jmcc.1995. 0237.

(34.) Slot IG, Schols AM, Vosse BA, Kelders MC, Gosker HR. Hypoxia differentially regulates muscle oxidative fiber type and metabolism in a HIF-1a-dependent maner. Cell Signal 2014; 26: 1837-1845, doi: 10.1016/j.cellsig.2014.04.016.

(35.) Zile MR, Baicu CF. Alterations in bentricular bunction: diastolic heart failure. In: Mann DL (Editor), Heart failure: a companion to Braunwald's heart disease. 2nd edn. St. Louis: Elsevier Saunders; 2010. p 213-231.

(36.) Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 1993; 73: 184-192, doi: 10.1161/01.RES.73.1.184.

(37.) Kiss E, Ball NA, Kranias EG, Walsh RA. Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca(2+)-ATPase protein levels. Effects on [Ca.sup.2+] transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res 1995; 77: 759-764, doi: 10.1161/01.RES.77.4.759.

C.F.S.M.P. Silveira [1], D.H.S. Campos [1], P.P. Freire [1], A.F. Deus [1], K. Okoshi [1], C.R. Padovani [2] and A.C. Cicogna [1]

[1] Departamento de Clinica Medica, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brasil

[2] Departamento de Bioestatistica, Instituto de Biociencias, Universidade Estadual Paulista, Botucatu, SP, Brasil

Correspondence: C.F.S. Mazeto: <>

Received August 24, 2016 | Accepted February 10, 2017

Caption: Figure 1. Relationship between muscle length and resting tension (RT) of aortic stenosis (AoS, dark grey, n=32) and control groups (Sham, light grey, n=32), using the progression model adjusted according to groups. Data are reported as mean [+ or -]SD. P<0.05 (non-linear regression model adjustment using the minimum square method).

Caption: Figure 2. Influence of hypoxia (60 min) and reoxygenation (30 min) on (A) developed tension (DT - g/[mm.sup.2]) and (B) resting tension (RT - g/[mm.sup.2]) of isolated papillary muscle from aortic stenosis (AoS, n=18; dark gray columns) and control groups (Sham, n=16; light gray columns). Data are reported as means [+ or -] SD. *P<0.001, vs hypoxia (multivariate analysis for repeated measures model in independent groups, complemented with Bonferroni's multiple comparison test).

Caption: Figure 3. Protein expression of sarcoplasmic reticulum calcium ATPase (SERCA) (A) and phospholamban (PLB) (B) and relationship between SERCA and PLB (C), from aortic stenosis (AoS, n=6) and control group (Sham, n=6). Data are reported as means [+ or -]SD. P values were 0.32, 0.12, and 0.16, respectively, vs Sham (Student's t-test).

Caption: Figure 4. Histological image with Picrosirius red stain (40 x). A, Sham group; B, aortic stenosis (AoS) group. C, collagen level, % of total area analyzed with Picrosirius red technique from AoS (n= 8) and control groups (Sham, n=9). Data are reported as median, maximum and minimum. *P<0.05 vs Sham (Mann-Whitney's test).
Table 1. Postmortem structural study.

                     Sham                 AoS             P

BW (g)         312 [+ or -] 26      300 [+ or -] 22      0.06
LV/BW         2.03 [+ or -] 0.16   3.42 [+ or -] 0.53   <0.001
RV/BW         0.65 [+ or -] 0.07   0.84 [+ or -] 0.22   <0.001
AT/BW         0.27 [+ or -] 0.03   0.56 [+ or -] 0.19   <0.001
Lungs WW/DW   4.70 [+ or -] 0.21   4.83 [+ or -] 0.39    0.11
Liver WW/DW   3.24 [+ or -] 0.07   3.28 [+ or -] 0.14    0.17

Data are reported as means [+ or -] SD. Sham: control group submitted
to surgery without clipping, n=32; AoS: aortic stenosis group
submitted to surgery with clipping, n=32; BW: body weight; LV: left
ventricle; RV: right ventricle; AT: atria; WW: wet weight; DW: dry
weight. P value, AoS vs Sham (Student's t-test).

Table 2. Functional and structural study results of echocardiogram.

                   Sham                 AoS              P

HR (bpm)     305 [+ or -] 34      296 [+ or -] 32      0.288
LVDD (mm)   7.67 [+ or -] 0.56   7.86 [+ or -] 0.78    0.266
LVSD (mm)   3.58 [+ or -] 0.42   3.41 [+ or -] 1.18    0.458
RWT         0.35 [+ or -] 0.07   0.44 [+ or -] 0.10   < 0.001
LA/AO       1.46 [+ or -] 0.17   1.83 [+ or -] 0.42   < 0.001
EF (%)      0.90 [+ or -] 0.03   0.90 [+ or -] 0.10    0.773
FS (%)      29.8 [+ or -] 3.0    31.9 [+ or -] 10.0    0.268
E (cm/s)    86.9 [+ or -] 9.0     110 [+ or -] 29     < 0.001
A (cm/s)    59.6 [+ or -] 16.1   62.7 [+ or -] 25.7    0.56
E/A         1.52 [+ or -] 0.28   2.42 [+ or -] 1.54    0.025

Data are reported as means [+ or -] SD. Sham: control group submitted
to surgery without clipping, n=32; AoS: aortic stenosis group
submitted to surgery with clipping, n=32; HR: heart rate; LVDD
and LVSD: left ventricle diastolic and systolic diameter; RWT:
relative wall thickness; LA: left atrium diameter; AO: aorta
diameter; EF: ejection fraction; FS: midwall fraction shortening;
E/A: ratio between filling flow peak (E wave) and atrial contraction
flow peak (A wave). P value, AoS vs Sham (Student's t-test).

Table 3. Basal isometric contraction.


CSA ([mm.sup.2])                            0.93 [+ or -] 0.21
DT (g/[mm.sup.2])                           7.39 [+ or -] 1.39
RT (g/[mm.sup.2])                           0.72 [+ or -] 0.22
+ dT/dt (g x [mm.sup.-2] x [s.sup.-1]    1) 87.7 [+ or -] 18.0
- dT/dt (g x [mm.sup.-2] x [s.sup.-1]    1) 28.0 [+ or -] 6.6
TPT (ms)                                     165 [+ or -] 12

                                                AoS              P

CSA ([mm.sup.2])                         0.96 [+ or -] 0.21    0.428
DT (g/[mm.sup.2])                        7.06 [+ or -] 1.35    0.346
RT (g/[mm.sup.2])                        1.11 [+ or -] 0.29   < 0.001
+ dT/dt (g x [mm.sup.-2] x [s.sup.-1]    73.1 [+ or -] 16.2    0.001
- dT/dt (g x [mm.sup.-2] x [s.sup.-1]    29.4 [+ or -] 5.5     0.362
TPT (ms)                                  189 [+ or -] 18     < 0.001

Data are reported as means [+ or -] SD. Sham: control group submitted
to surgery without clipping, n=32; AoS: aortic stenosis group
submitted to surgery with clipping, n=32; extracellular calcium
concentration: 2.5 mM; CSA: aortic cross-sectional area; DT: maximum
developed tension; RT: resting tension; +dT/dt: maximum rate of
tension development; -dT/dt: maximum rate of tension decline;
TPT: time-to-peak tension. P value, AoS vs Sham (Student's t-test).

Table 4. Cyclopiazonic experiment.

                                Calcium concentration
                       0.5 mM                  0.5 mM
DT (%)
  Sham          56.3 (25.9; 97.9)a A    73.0 (44.4; 81.9)a AB
  AoS           73.2 (58.6; 92.7)b A    80.7 (69.1; 91.0)b AB
RT (%)
  Sham          89.5 (71.0; 122.2)a A   92.8 (79.3; 148.6)a A
  AoS           91.6 (76.6; 105.3)a A   98.5 (84.4; 104.7)a B
  - dT/dt (%)
  Sham          57.1 (18.9; 83.1)a A    59.7 (43.2; 82.8)a A
  AoS           68.3 (41.8; 77.9)a A    58.6 (53.0; 68.1)a A

                Calcium concentration
                       2.5 mM
DT (%)
  Sham          77.6 (63.0; 97.2)a B
  AoS           83.7 (77.5; 92.4)b B
RT (%)
  Sham          94.9 (79.3; 140.0)a A
  AoS           97.7 (81.6; 111.1)a B
  - dT/dt (%)
  Sham          63.4 (53.0; 79.5)b A
  AoS           55.5 (47.0; 72.9)a A

Data are reported as median, minimum and maximum values, regarding
basal condition, in percentage (%). Sham: control group, submitted to
surgery without clip placement, n=15; AoS: aortic stenosis group,
submitted to surgery with clip placement, n=11; DT: developed
tension; RT: resting tension; -dT-dt: maximum relaxation speed.
Lower-case letters: comparison between groups within a calcium
concentration; Upper-case letters: comparison between calcium
concentrations within a group. P<0.05 vs Sham (ANOVA, complemented by
Student-Newman-Keuls multiple comparisons test).
COPYRIGHT 2017 Associacao Brasileira de Divulgacao Cientifica (ABDC)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:sarcoplasmic reticulum calcium ATPase cardiac isoform 2a
Author:Silveira, C.F.S.M.P.; Campos, D.H.S.; Freire, P.P.; Deus, A.F.; Okoshi, K.; Padovani, C.R.; Cicogna,
Publication:Brazilian Journal of Medical and Biological Research
Article Type:Report
Date:May 1, 2017
Previous Article:Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital.
Next Article:Erratum for: Primary cultures of mouse small intestinal epithelial cells using the dissociating enzyme type I collagenase and hyaluronidase.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |